Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

Green International University

ClinicalTrials.gov lists Green International University as lead sponsor of 16 trials.

PK Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Disease areas Disease areas 21 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 3 Journals published in Journals published in 8 Latest dated events Latest dated events 19 Biomarker capability evidence Biomarker capability evidence 2 Disease areas Disease areas 21 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 3 Journals published in Journals published in 8 Latest dated events Latest dated events 19 Biomarker capability evidence Biomarker capability evidence 2

Rows recorded per section

19 sections measured, none recorded

This page covers Green International University: 16 lead-sponsored trials and 1 legal-entity registration.

Get the Green International University report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (21)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Pain 7
Neck Pain 2
Patellofemoral Pain Syndrome 2
Anterior Cruciate Ligament Injuries 1
Arthralgia 1

Trials by start year as sponsor or collaborator (3)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 5
2025 12
2024 2

No forecast is made for this organization: it averages 3.8 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 16 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Journals published in (8)

Shown in this order: most published in first.

Journals published in
Journal Publications
American journal of epidemiology 1
BMJ (Clinical research ed.) 1
International journal of epidemiology 1
Internet interventions 1
Lancet (London, England) 1

Latest dated events (19)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-09-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-25 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-04-06 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-04-06 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-04-06 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (2)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
LBP Trial sponsor Named in trial inclusion criteria
LBP Trial sponsor Mentioned in trial text

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.